Biomerica Inc (BMRA)

Jan 09, 2026

How interest rate cuts could boost Biomerica Inc. stockPortfolio Value Summary & Free Verified High Yield Trade Plans - ulpravda.ru

Jan 09, 2026

Jan 08, 2026

Will Biomerica Inc. stock maintain dividend yield2025 Key Highlights & Expert Approved Momentum Ideas - ulpravda.ru

Jan 08, 2026

Jan 08, 2026

Is Biomerica Inc. stock safe for conservative investorsBuy Signal & Reliable Breakout Forecasts - ulpravda.ru

Jan 08, 2026

Jan 08, 2026

How Biomerica Inc. stock responds to policy changesInsider Selling & Weekly Setup with ROI Potential - ulpravda.ru

Jan 08, 2026

Jan 07, 2026

Biomerica Adds Most New Retail Followers Among Biotechs After UAE Nod For Prostate Cancer Screening Test - MSN

Jan 07, 2026

Jan 07, 2026

Biomerica (NASDAQ:BMRA) Stock Crosses Below Two Hundred Day Moving Average – Time to Sell? - Defense World

Jan 07, 2026

Jan 04, 2026

Biomerica (BMRA) Stock Analysis Report | Ratings, Financials & Performance - Benzinga España

Jan 04, 2026

Dec 24, 2025

Biomerica stock soars after Medicare sets $300 payment rate for IBS test - Investing.com Australia

Dec 24, 2025

Dec 23, 2025

Medicare to pay $300 for Biomerica’s IBS test starting January 2026 - Investing.com Nigeria

Dec 23, 2025

Dec 23, 2025

Biomerica Gains Exposure as Distribution Expands in Egypt - StocksToTrade

Dec 23, 2025

Dec 23, 2025

Biomerica’s Market Presence Expands with Egyptian Drug Authority Authorization - timothysykes.com

Dec 23, 2025

Dec 23, 2025

Biomerica stock soars after Medicare sets $300 payment rate for IBS test By Investing.com - Investing.com Nigeria

Dec 23, 2025

Dec 23, 2025

Medicare to pay $300 for Biomerica’s IBS test starting January 2026 By Investing.com - Investing.com South Africa

Dec 23, 2025

Dec 23, 2025

Biomerica, Inc. Announces Medicare Payment Rate for inFoods® IBS Test Set at $300 Effective January 1, 2026 - Quiver Quantitative

Dec 23, 2025

Dec 23, 2025

Biomerica Announces CMS Medicare Payment Rate of $300 for Revolutionary inFoods® IBS Test - The Manila Times

Dec 23, 2025

Dec 23, 2025

Biomerica announces CMS Medicare payment rate of $300 for revolutionary Infoods® IBS test - marketscreener.com

Dec 23, 2025

Dec 23, 2025

Medicare sets $300 price for new food-trigger test to ease IBS pain - Stock Titan

Dec 23, 2025

Dec 21, 2025

Why Biomerica Inc. stock remains a top recommendationJuly 2025 Analyst Calls & Verified Technical Trade Signals - Улправда

Dec 21, 2025

Dec 20, 2025

Biomerica stockholders approve key proposals at annual meeting - MSN

Dec 20, 2025

Dec 19, 2025

Will Biomerica Inc. stock attract more institutional investorsTrade Signal Summary & Expert Verified Movement Alerts - Улправда

Dec 19, 2025

Dec 19, 2025

Market Review: Is Biomerica Inc. stock a safe haven assetMarket Activity Recap & Scalable Portfolio Growth Methods - Улправда

Dec 19, 2025

Dec 19, 2025

Will Biomerica Inc. stock recover faster than marketWeekly Market Report & Consistent Income Trade Ideas - Улправда

Dec 19, 2025

Dec 19, 2025

Can Biomerica Inc. stock maintain operating marginsTrade Volume Report & Stock Portfolio Risk Management - Улправда

Dec 19, 2025

Dec 19, 2025

What makes Biomerica Inc. stock attractive to growth fundsSmall Cap Stock Opportunities & Minimal Capital Investment - ulpravda.ru

Dec 19, 2025

Dec 19, 2025

Is Biomerica Inc. stock a safe haven assetJuly 2025 PostEarnings & AI Enhanced Market Trend Forecasts - Улправда

Dec 19, 2025

Dec 19, 2025

Biomerica Earnings Notes - Trefis

Dec 19, 2025

Dec 17, 2025

Biomerica (NASDAQ:BMRA) Stock Crosses Below 200-Day Moving Average – What’s Next? - Defense World

Dec 17, 2025

Dec 16, 2025

Biomerica Stockholders Approve Key Proposals at Annual Meeting - TipRanks

Dec 16, 2025

Dec 12, 2025

Egyptian drug authority approves Biomerica’s cancer screening portfolio By Investing.com - Investing.com Australia

Dec 12, 2025

Dec 11, 2025

Biomerica (BMRA) Gains Approval for Rapid Tests in Egypt - GuruFocus

Dec 11, 2025

Dec 11, 2025

Egyptian drug authority approves Biomerica’s cancer screening portfolio - Investing.com

Dec 11, 2025

Dec 11, 2025

Biomerica, Inc. Receives Authorization from Egyptian Drug Authority for Comprehensive Cancer and Chronic Disease Screening Portfolio - Quiver Quantitative

Dec 11, 2025

Dec 09, 2025

Biomerica (NASDAQ:BMRA) versus ProKidney (NASDAQ:PROK) Critical Review - Defense World

Dec 09, 2025

Dec 06, 2025

Retail Trends: Why Biomerica Inc stock is recommended by analystsRisk Management & Target Return Focused Stock Picks - BỘ NỘI VỤ

Dec 06, 2025

Dec 05, 2025

Why Biomerica Inc. stock is recommended by analystsJuly 2025 Drop Watch & Free Expert Verified Stock Movement Alerts - Newser

Dec 05, 2025

Dec 05, 2025

Is Biomerica Inc. stock a good choice for value investorsJuly 2025 Big Picture & AI Enhanced Trading Alerts - Newser

Dec 05, 2025

Dec 01, 2025

Biomerica Expands Contract Manufacturing Services - Orange County Business Journal

Dec 01, 2025

Nov 25, 2025

Biomerica's inFoods IBS Product Featured in Biotherapeutics Quarterly - MarketScreener

Nov 25, 2025

Nov 25, 2025

Biomerica (BMRA) Showcases Innovative IBS Therapy in Biotherapeu - GuruFocus

Nov 25, 2025

Nov 25, 2025

Biomerica, Inc. Announces Positive Results from Multicenter Clinical Trial on inFoods® IBS Dietary Therapy - Quiver Quantitative

Nov 25, 2025

Nov 25, 2025

Biomerica’s inFoods® IBS Product Featured in Biotherapeutics Quarterly, a Henry Schein Publication, Highlighting a New Precision Approach for Treating IBS - The Manila Times

Nov 25, 2025

Nov 21, 2025

Biomerica Inc. (BMRA) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Nov 21, 2025

Nov 19, 2025

Why Biomerica Inc. stock appeals to analystsMarket Performance Recap & Breakout Confirmation Alerts - newser.com

Nov 19, 2025

Nov 19, 2025

Is Biomerica Inc. stock vulnerable to regulatory risksAnalyst Upgrade & Low Drawdown Trading Strategies - newser.com

Nov 19, 2025

Nov 19, 2025

What momentum shifts mean for Biomerica Inc.Portfolio Value Report & Safe Entry Momentum Tips - newser.com

Nov 19, 2025